HealthWatchlist verdict: Essential oils are not established cold-sore treatments. A lemon-balm extract trial is often confused with essential-oil evidence, and laboratory antiviral activity does not show that applying an oil heals a cold sore.
What a cold sore is
Cold sores usually begin with tingling and develop into blisters around the mouth. They differ from the mouth ulcers commonly called canker sores. That distinction matters because different causes need different care.
Cold sores can spread from the first warning sensations until fully healed. An improvement in pain or appearance does not demonstrate that a product has made the lesion non-infectious.
Comparing the common claims
| Claim | What was studied | Main limitation |
|---|---|---|
| Tea tree oil heals cold sores | A small gel study and later trial-methodology report exist. | They do not establish dependable benefit from a household essential oil. |
| Melissa oil has clinical proof | A trial tested a standardised lemon-balm leaf extract cream. | An extract cream is not the same as distilled essential oil. |
| Antiviral activity proves cure | Many studies expose viruses or infected cells to substances in a laboratory. | That is not a clinical healing or transmission outcome. |
| A stronger concentration works faster | No reliable basis for this home-use claim. | Irritation may worsen an already painful area. |
The lemon-balm trial is relevant, but it is not an oil trial
A randomised trial in 66 people tested a cream containing a standardised dried Melissa officinalis leaf extract. It reported a better combined symptom score than placebo on the second treatment day. That is a relevant clinical observation for the particular cream.
The preparation was an extract, not distilled lemon-balm essential oil. Its results do not establish that another Melissa product has the same composition, dose or effect. Nor does a short symptom-score result establish eradication of herpes or prevention of transmission.
What the tea tree reports can tell us
A 2001 report studied a 6% tea tree gel for recurrent cold sores. It is an early clinical lead, rather than a sufficient basis for a general treatment recommendation. The bibliographic record alone does not provide the detailed outcome reporting needed for a confident numerical claim here.
A later paper examined blinding in a tea tree cold-sore trial. It considered whether participants could identify their allocated ointment. That is useful research methodology, but successful blinding is not itself evidence that the treatment healed lesions faster.
This distinction is easy to miss when search results display several papers about the same intervention. A methods paper, a pilot report and a treatment trial are not automatically three independent demonstrations of benefit.
Why antiviral experiments are not enough
Research on Melissa extract tested viral attachment and penetration in laboratory systems. Another study examined an extract against herpes simplex type 2 in cultured cells. Neither establishes that a distilled oil treats a person’s cold sore.
The concentration that affects free viral particles may differ from one safe on damaged lips. Timing also matters: exposure before infection in a laboratory cannot be assumed to reproduce treatment after a lesion appears.
Claims that an oil “kills herpes” often ignore the difference between a laboratory observation and a persistent infection in the body. A topical product should not be presented as removing the virus or eliminating recurrence.
Practical care and preventing spread
A pharmacist can advise on recognised cold-sore products. NHS guidance notes that antiviral creams are most useful when started at the early tingling stage. Seek advice if a sore is unusually large, very painful or has not begun healing within about ten days.
Wash your hands after touching the area and avoid kissing or oral sex until it heals. Do not kiss a baby while you have a cold sore: neonatal herpes can be serious. Oil use does not change these precautions.
A painful red eye, light sensitivity or vision changes can indicate eye involvement. Seek urgent assessment rather than applying oil near the eye. People with weakened immunity should also seek medical advice rather than rely on a home remedy.
Safety and conclusion
Tea tree oil should not be swallowed. Lips and the inside of the mouth are particularly unsuitable places to experiment with concentrated oils. Essential-oil contact allergy can add another problem to the original lesion.
There are genuine research questions around formulated botanical products. The available findings do not justify treating a commercial essential oil as a proven cold-sore medicine, or ignoring established care and transmission precautions.
How this review was researched
Research checked on 12 September 2026. We searched PubMed using the oil or preparation name and the condition, checked relevant reviews and their cited trials, and consulted the official guidance linked below. This is an editorial review, not an exhaustive systematic review. Laboratory findings, combination products and uncontrolled reports are distinguished from controlled evidence for the exact claim.
Related reading
References
- Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
- Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis.
- Use of deception to achieve double-blinding in a clinical trial of Melaleuca alternifolia (tea tree) oil for the treatment of recurrent herpes labialis.
- Attachment and penetration of acyclovir-resistant herpes simplex virus are inhibited by Melissa officinalis extract.
- Inhibitory activity of Melissa officinalis L. extract on Herpes simplex virus type 2 replication.
- NHS: Cold sores
- NHS: Neonatal herpes
- NHS: Herpes simplex eye infections
- NCCIH: Tea tree oil, usefulness and safety
- DermNet: Allergic contact dermatitis to essential oils